Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Menactra Booster Response in Saudi Adolescents
NCT00444951Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2007
- Primary completion
- Feb 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of meningococcal A conjugate vaccine in meningococcal infection (3 arms), sponsored by Sanofi. Primary endpoint: Geometric Mean Titers (GMTs) of Vaccine Serogroups Determined by Serum Bactericidal Activity Using Baby Rabbit Complement (SBA-BR) at Day 28. Started Feb 2007; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00444951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00444951.